院内心脏骤停病因与30天后长期生存:瑞典心肺复苏登记研究
本研究基于瑞典心肺复苏登记,纳入2018至2023年成人院内心脏骤停且存活≥30天的患者2692例,按病因分为心肌缺血(参照)、其他心脏、肺部、感染、出血和其他非心脏六类,用Cox回归分析全因死亡。中位随访3.7年期间886例死亡(33%),总体一年生存率86%。完全校正后,感染(HR 1.79,95%CI 1.30-2.47)、出血(HR 1.71,95%CI 1.20-2.43)和肺部病因(HR 1.61,95%CI 1.24-2.11)的长期死亡风险高于心肌缺血,其他心脏和其他非心脏病因无差异。结论认为院内心脏骤停病因与30天存活后的长期预后独立相关,支持按病因进行随访。
要点
- 院内心脏骤停30天存活者中,感染病因长期全因死亡风险高于心肌缺血(HR 1.79,95%CI 1.30-2.47)。
- 出血病因长期全因死亡风险高于心肌缺血(HR 1.71,95%CI 1.20-2.43)。
- 肺部病因长期全因死亡风险高于心肌缺血(HR 1.61,95%CI 1.24-2.11)。
- 其他心脏病因和其他非心脏病因与心肌缺血相比,长期死亡风险无显著差异。
- 2692例30天存活者中位随访3.7年期间886例死亡(33%),总体一年生存率86%。
适用人群与场景
- 2018至2023年瑞典成人院内心脏骤停且存活≥30天的患者,共2692例,中位年龄71岁,67%为男性。
研究设计与关键结果
- 全国登记-based队列研究,纳入2692例30天存活者,中位随访3.7年,886例死亡(33%),总体一年生存率86%。
- 完全校正模型(人口学、合并症、骤停特征)中,感染病因全因死亡风险高于心肌缺血(HR 1.79,95%CI 1.30-2.47)。
- 出血病因全因死亡风险高于心肌缺血(HR 1.71,95%CI 1.20-2.43)。
- 肺部病因全因死亡风险高于心肌缺血(HR 1.61,95%CI 1.24-2.11)。
- 其他心脏病因和其他非心脏病因与心肌缺血相比,长期死亡风险无显著差异。
证据类型、等级与局限
- 证据类型:全国登记-based队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,院内心脏骤停病因与30天存活后的长期预后独立相关,支持按病因进行随访。
- 对感染、出血和肺部病因的院内心脏骤停30天存活者,其长期死亡风险高于心肌缺血病因者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To investigate whether the aetiology of in-hospital cardiac arrest (IHCA) is associated with long-term survival after 30-day survival.
METHODS: A nationwide registry-based cohort study was conducted using the Swedish Registry for Cardiopulmonary Resuscitation. Adult IHCA patients in Sweden between 2018 and 2023 who survived ≥30 days were included. Aetiologies were merged into six categories (myocardial ischemia [reference], other cardiac, pulmonary, infectious, haemorrhagic and other non-cardiac). Cox (proportional hazards) regression models were used to estimate crude and multivariable adjusted (demographics, comorbidities, arrest characteristics) hazard ratios (HRs) with 95% CIs for all-cause mortality.
RESULTS: Among 2692 30-day survivors (median age 71 years; 67% male), 886 deaths (33%) occurred over a median 3.7-year follow-up; overall one‑year survival was 86%. In the fully adjusted model, higher hazards of death were observed for infectious (HR 1.79, 95% CI 1.30-2.47), haemorrhagic (1.71, 1.20-2.43), and pulmonary aetiologies (1.61, 1.24-2.11), compared to myocardial ischemia. No difference was observed for cardiac and other non‑cardiac aetiologies.
CONCLUSIONS: Aetiology of in-hospital cardiac arrest is independently associated with long‑term prognosis after 30‑day survival. Compared with myocardial ischemia, infectious, haemorrhagic and pulmonary causes are associated with higher long‑term mortality. These findings support aetiology‑informed follow‑up after IHCA.
参考来源
- Bruchfeld S, Djärv T, Riva G, et al. Aetiology of in-hospital cardiac arrest and long-term survival after the first 30 days: insights from the Swedish registry for cardiopulmonary resuscitation. Resuscitation. 2026. PMID: 41548749. doi:10.1016/j.resuscitation.2026.110972
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。